The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs, And Conference Presentations In The Spotlight

Wednesday, Feb. 10:

  • Polypid Ltd (PYPD) (before the market open).
  • Veru Inc (VERU) (before the market open).
  • Vanda Pharmaceuticals Inc. (VNDA) (after the market close).
  • Pacific Biosciences of California Inc (PACB) (after the market close).
  • Fluidigm Corporation (FLDM) (after the market close).
  • Exelixis, Inc. (EXEL) (after the market close).
  • Aethlon Medical, Inc. (AEMD) (after the market close).

Thursday, Feb. 11:

  • Karyopharm Therapeutics Inc (KPTI) (before the market open).
  • Myovant Sciences Ltd (MYOV) (before the market open).
  • Alnylam Pharmaceuticals, Inc. (ALNY) (before the market open).
  • Applied Genetic Technologies Corp (AGTC) (before the market open).
  • Alkermes Plc (ALKS) (before the market open).
  • Laboratory Corp. of America Holdings (LH) (before the market open).
  • AVITA Medical Inc (RCEL) (after the market close).
  • Aytu Bioscience Inc (AYTU) (after the market close).
  • Otonomy Inc (OTIC) (after the market close).
  • Illumina, Inc. (ILMN) (after the market close).
  • Ultragenyx Pharmaceutical Inc (RARE) (after the market close).

Friday, Feb. 12:

  • ImmunoGen, Inc. (IMGN) (before the market open).


Adagene, Inc., a China-based, clinical-stage biopharmaceutical company developing antibody-based cancer immunotherapies, has filed to offer 7.354 million ADSs, representing 9,1925 million ordinary shares, in an initial public offering. The company expects to price the offering in the $17-$19 range, and has applied for listing its ADSs on the Nasdaq under the ticker symbol ADAG.

French clinical-stage biotech Biophytis S.A., which focuses on development of therapeutics that slow the degenerative processes associated with aging, is proposing to offer 1.2 million ADSs in an IPO. Each ADS represents the right to receive 10 ordinary shares. The offering price is expected to be between $15 and $18 per ADS. The company has applied to list its ADSs on the Nasdaq under the ticker symbol BPTS.

View single page >> |

© 2021 Benzinga does not provide investment advice. All rights reserved.

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.